• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Pfiz­er wants you. And you. And you. And you.

9 years ago
Deals

Bio­gen spin­off be­gins trad­ing to­day; New on­col­o­gy chief at As­traZeneca

9 years ago
News Briefing

As Trump fin­gers phar­ma on drug prices, ex­ecs step up with the lat­est vows of self dis­ci­pline

9 years ago
Pharma

Vi­sion or voodoo? Biotech IPO mas­ter Vivek Ra­maswamy is still set­ting up new biotechs and hatch­ing more deals

9 years ago
People
Financing

FDA re­jects Tesaro’s IV ver­sion of ro­lap­i­tant, cit­ing man­u­fac­tur­ing is­sues

9 years ago
Pharma

Cure­Vac’s lead mR­NA pro­gram flunks a crit­i­cal PhI­Ib study, rais­ing ques­tions for high-pro­file biotech uni­corns

9 years ago
R&D

Don­ald Trump promis­es to slash drug prices by bil­lions, pledg­ing ag­gres­sive fed­er­al bid­ding process

9 years ago
Pharma

Eli Lil­ly, Mer­ck add new com­bo al­liance; Gilead re­al­ly does want to fo­cus on M&A

9 years ago
News Briefing

Dai­ichi Sankyo launch­es glob­al R&D re­struc­tur­ing, look­ing to slash costs in an over­haul

9 years ago
R&D
Pharma

In a stun­ner, Mer­ck leaps ahead of ri­vals with com­bo Keytru­da/chemo at­tack on lung can­cer

9 years ago
R&D
Pharma

Mer­ck KGaA splurges $230M on its pipeline, pay­ing Ver­tex for a slate of ear­ly-stage can­cer drugs

9 years ago
Pharma

A hun­gry Take­da con­tin­ues deal spree with $125M T cell pact, op­tion to buy

9 years ago
Pharma

Strug­gling Sarep­ta bounces back as an­a­lysts cheer the first trick­le of rev­enue for DMD drug

9 years ago
R&D
Pharma

Valeant auc­tions off Den­dreon, skin­care as­sets; Bay­er to col­lab­o­rate with the Uni­ver­si­ty of Pitts­burgh

9 years ago
News Briefing

J&J In­no­va­tion ex­pands its biotech in­cu­ba­tor JLABS in­to Man­hat­tan

9 years ago
Pharma

Bio­gen CEO Michel Vounatsos re­groups and stakes out a BD plan for 2017

9 years ago
People
R&D

Se­cre­tive? Mod­er­na de­tails its pipeline strat­e­gy at JPM but at least one crit­ic bites back

9 years ago
R&D

Fresh from grab­bing Shire’s mR­NA work, RaNA dis­clos­es a $51M raise

9 years ago
Pharma

Kite lines up a JV in Chi­na while Dai­ichi Sankyo strikes $250M-plus deal to launch CAR-T drug in Japan

9 years ago
R&D
Pharma

Am­gen, Sanofi and Mer­ck an­nounce a string of deals at #JPM17; Mc­Do­nough out at So­bi

9 years ago
News Briefing

Al­ler­gan bags two new deals, takes op­tion to buy Lyso­so­mal Ther­a­peu­tics and pays $50M for mi­cro­bio­me pact

9 years ago
Pharma

Take­da grabs Ari­ad, ex­pands on­col­o­gy port­fo­lio in $5.2B buy­out

9 years ago
Deals

Cel­gene antes up $55M, grabs op­tion to buy the au­toim­mune up­start Anokion

9 years ago
Deals

Savara jump­ing to the NYSE in re­verse merg­er with zom­bie biotech Mast

9 years ago
Deals
First page Previous page 1135113611371138113911401141 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.